CanSino Biologics (HKSE:06185) EV-to-EBITDA : -3.56 (As of May. 15, 2024)

CanSino Biologics EV-to-EBITDA Chart

CanSino Biologics Quarterly Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBITDA	Get a 7-Day Free Trial													-7.09	-1.69	-1.66	-2.38	-0.91

Competitive Comparison of CanSino Biologics's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanSino Biologics's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's EV-to-EBITDA falls into.

CanSino Biologics EV-to-EBITDA Calculation

CanSino Biologics's EV-to-EBITDA for today is calculated as:

CanSino Biologics's current Enterprise Value is HK$7,318.7 Mil.
CanSino Biologics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-2,055.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanSino Biologics  (HKSE:06185) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CanSino Biologics's PE Ratio for today is calculated as:

CanSino Biologics's share price for today is HK$21.15.
CanSino Biologics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-6.687.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

CanSino Biologics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

CanSino Biologics (HKSE:06185) Business Description